Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.
Saved in:
| Title: | Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice. |
|---|---|
| Authors: | Andreev K; Department Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA., Jones JC; Department Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA., Kandeil A; Department Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA.; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt., Vogel P; Department of Comparative Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Webby RJ; Department Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA., Govorkova EA; Department Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA. elena.govorkova@stjude.org. |
| Source: | Nature communications [Nat Commun] 2026 Feb 19; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-69721-5 |
